The week’s biotech discoveries include an insulin-related gene mutation and the news that previously ignored brain structures could govern obesity.

Researchers discovered a new mechanism that regulates the protein titin, which plays a key role in helping muscles function—especially in the heart.

NIH scientists have modeled the 3D structure of DHHC enzymes, which modify EGFRs, which are implicated in a range of cancers.

Scientists at Rice University say they have created a toolkit of gene “promoters” that can turn genes on and off at command.

Scientists at the University of Queensland are attacking antibiotics-resistant bacteria by re-engineering vancomycin.

UNC scientists unraveled the structure of an opioid receptor, which could allow for the design of painkillers that do not cause side effects.

A University of Pittsburgh team is using a viral vector to deliver proteins into the pancreas that transform alpha cells into insulin-producing cells.

Oncolytic viruses used in tandem with other treatments could be key for difficult-to-treat breast and brain cancers.

An experimental three-part drug originally developed for use in Type 2 diabetes seems to reverse memory loss in mice.